Wsd Medi Clinical Sp. z o.o.
- Address
- lock Available on a paid plan
WSD Medi Clinical - Inflammatory and Oncologic Disease Research
WSD Medi Clinical Sp. z o.o. is a specialized clinical research center with extensive expertise in evaluating novel therapeutic interventions for inflammatory bowel diseases and advanced oncological conditions. The center demonstrates particular proficiency in conducting complex Phase 2 and Phase 3 trials involving biologics and targeted therapies, with a strong focus on both induction and maintenance treatment protocols.
- Inflammatory Bowel Disease research, including Crohn's disease (moderate to severe, fibrostenotic variants) and ulcerative colitis
- Advanced and metastatic breast cancer trials, particularly hormone receptor-positive, HER2-negative disease
- Autoimmune and inflammatory conditions, including rheumatoid arthritis
The center's research portfolio showcases comprehensive experience with endoscopic endpoints, clinical remission assessments, and long-term maintenance studies. Their involvement in multiple concurrent inflammatory bowel disease trials, ranging from novel biologics to subcutaneous formulations, demonstrates their capacity to manage complex patient populations requiring specialized gastroenterological expertise. WSD Medi Clinical also contributes to oncology research through participation in combination therapy trials for HR-positive, HER2-negative metastatic breast cancer, evaluating innovative treatment approaches including CDK4/6 inhibitors and targeted therapies in first-line settings.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 therapeutic areas and 15 of 27 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +7 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Wsd Medi Clinical Sp. z o.o.
lock Showing 1 of 26 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Protocol to Evaluate the Efficacy and Safety of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Janssen Cilag International | Phase IV | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 27 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.